136 related articles for article (PubMed ID: 12580968)
1. Cell surface CD43 determination improves diagnostic precision in late B-cell diseases.
Jung G; Eisenmann JC; Thiébault S; Hénon P
Br J Haematol; 2003 Feb; 120(3):496-9. PubMed ID: 12580968
[TBL] [Abstract][Full Text] [Related]
2. A new score including CD43 and CD180: Increased diagnostic value for atypical chronic lymphocytic leukemia.
Li Y; Tong X; Huang L; Li L; Wang C; He C; Liu S; Wang Z; Xiao M; Mao X; Zhang D
Cancer Med; 2021 Jul; 10(13):4387-4396. PubMed ID: 34061467
[TBL] [Abstract][Full Text] [Related]
3. Determination of CD43 and CD200 surface expression improves accuracy of B-cell lymphoma immunophenotyping.
Hoffmann J; Rother M; Kaiser U; Thrun MC; Wilhelm C; Gruen A; Niebergall U; Meissauer U; Neubauer A; Brendel C
Cytometry B Clin Cytom; 2020 Nov; 98(6):476-482. PubMed ID: 32716606
[TBL] [Abstract][Full Text] [Related]
4. Quantitative assessment of informative immunophenotypic markers increases the diagnostic value of immunophenotyping in mature CD5-positive B-cell neoplasms.
Starostka D; Kriegova E; Kudelka M; Mikula P; Zehnalova S; Radvansky M; Papajik T; Kolacek D; Chasakova K; Talianova H
Cytometry B Clin Cytom; 2018 Jul; 94(4):576-587. PubMed ID: 29220870
[TBL] [Abstract][Full Text] [Related]
5. The value of the monoclonal antibody, DBA44, in the diagnosis of B-lymphoid disorders.
Salomon-Nguyen F; Valensi F; Troussard X; Flandrin G
Leuk Res; 1996; 20(11-12):909-13. PubMed ID: 9009248
[TBL] [Abstract][Full Text] [Related]
6. The Role of CD200 and CD43 Expression in Differential Diagnosis between Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma.
Falay M; Afacan Öztürk B; Güneş K; Kalpakçı Y; Dağdaş S; Ceran F; Özet G
Turk J Haematol; 2018 May; 35(2):94-98. PubMed ID: 28713070
[TBL] [Abstract][Full Text] [Related]
7. Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b).
Moreau EJ; Matutes E; A'Hern RP; Morilla AM; Morilla RM; Owusu-Ankomah KA; Seon BK; Catovsky D
Am J Clin Pathol; 1997 Oct; 108(4):378-82. PubMed ID: 9322589
[TBL] [Abstract][Full Text] [Related]
8. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.
Matutes E; Owusu-Ankomah K; Morilla R; Garcia Marco J; Houlihan A; Que TH; Catovsky D
Leukemia; 1994 Oct; 8(10):1640-5. PubMed ID: 7523797
[TBL] [Abstract][Full Text] [Related]
9. Frequency of CD43 expression in non-Hodgkin lymphoma. A survey of 742 cases and further characterization of rare CD43+ follicular lymphomas.
Lai R; Weiss LM; Chang KL; Arber DA
Am J Clin Pathol; 1999 Apr; 111(4):488-94. PubMed ID: 10191768
[TBL] [Abstract][Full Text] [Related]
10. The utility of CD20 and CD43 in subclassification of low-grade B-cell lymphoma on paraffin sections.
Contos MJ; Kornstein MJ; Innes DJ; Ben-Ezra J
Mod Pathol; 1992 Nov; 5(6):631-3. PubMed ID: 1285443
[TBL] [Abstract][Full Text] [Related]
11. [CD43 in B-cell chronic lymphocytic leukemia].
Roliński J; Rupniewska ZM; Dmoszyńska A; Wasik-Szczepanek E; Bojarska-Junak A
Pol Arch Med Wewn; 1999 Sep; 102(3):753-62. PubMed ID: 10949882
[TBL] [Abstract][Full Text] [Related]
12. Diffuse low-grade B-cell lymphomas. Four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features.
Zukerberg LR; Medeiros LJ; Ferry JA; Harris NL
Am J Clin Pathol; 1993 Oct; 100(4):373-85. PubMed ID: 8213632
[TBL] [Abstract][Full Text] [Related]
13. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
14. CD5-expressing B-cell lymphomas/leukemias: relatively high frequency of CD5+ B-cell lymphomas with an overall poor prognosis in Nagasaki Japan.
Kamihira S; Hirakata Y; Atogami S; Sohda H; Tsuruda K; Yamada Y; Tomonaga M
Leuk Lymphoma; 1996 Jun; 22(1-2):137-42. PubMed ID: 8724541
[TBL] [Abstract][Full Text] [Related]
15. Coexpression of CD43 by benign B cells in the terminal ileum.
Lee PS; Beneck D; Weisberger J; Gorczyca W
Appl Immunohistochem Mol Morphol; 2005 Jun; 13(2):138-41. PubMed ID: 15894925
[TBL] [Abstract][Full Text] [Related]
16. Identification of tumours with the CD43 only phenotype during the investigation of suspected lymphoma: a heterogeneous group not necessarily of T cell origin.
Kennedy GA; Cull G; Gill D; Marlton P; Norris D; Cobcroft R
Pathology; 2002 Feb; 34(1):46-50. PubMed ID: 11902445
[TBL] [Abstract][Full Text] [Related]
17. Classification of small B-cell lymphoid neoplasms using a paraffin section immunohistochemical panel.
Chen CC; Raikow RB; Sonmez-Alpan E; Swerdlow SH
Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):1-11. PubMed ID: 10937042
[TBL] [Abstract][Full Text] [Related]
18. CD43 expression in B cell lymphoma.
Treasure J; Lane A; Jones DB; Wright DH
J Clin Pathol; 1992 Nov; 45(11):1018-22. PubMed ID: 1280654
[TBL] [Abstract][Full Text] [Related]
19. Role of CD200 in differential diagnosis of mature B-cell neoplasm.
Rahman K; Kumar P; Gupta R; Singh MK; Nityanand S
Int J Lab Hematol; 2017 Aug; 39(4):384-391. PubMed ID: 28422443
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of an immunohistochemical panel in paraffin-embedded tissues for the differentiation of B-cell non-Hodgkin's lymphomas of small lymphocytes.
de Leon ED; Alkan S; Huang JC; Hsi ED
Mod Pathol; 1998 Nov; 11(11):1046-51. PubMed ID: 9831200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
